Neuropeptidergic inhibitory regulation of Met-enkephalin immunoreactive material release from rat spinal cord in vitro

Peptides. 1984 Sep-Oct;5(5):849-52. doi: 10.1016/0196-9781(84)90104-9.

Abstract

The release of Met-enkephalin immunoreactive material (ME-IR) from rat spinal slices was measured in vitro. This release increased about 4 fold in response to the addition of K+ ions. K+-evoked release of ME-IR was Ca++ dependent. Veratridine, a depolarizing agent, also stimulated the release of ME-IR. Veratridine-induced ME-IR release was completely prevented by tetrodotoxin (TTX), a Na+ channel blocker. Somatostatin (SRIF) inhibited both basal and K+-evoked release of ME-IR at 10(-7) M. Substance P had a similar effect although higher concentrations were needed. gamma-Aminobutyric acid (GABA) and neurotensin (NT) did not affect the basal release but slightly decreased K+-evoked release at 10(-5) M. Serotonin (5-HT) and noradrenaline (NA), did not affect ME-IR release. These results suggest that some of the neuropeptides present in the spinal cord, especially SP and SRIF, may be potent modulators of ME-IR release at the spinal level.

MeSH terms

  • Animals
  • Enkephalin, Methionine / metabolism*
  • Male
  • Neurotensin / pharmacology
  • Neurotransmitter Agents / pharmacology*
  • Norepinephrine / pharmacology
  • Potassium / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Serotonin / pharmacology
  • Somatostatin / pharmacology
  • Spinal Cord / drug effects
  • Spinal Cord / metabolism*
  • Substance P / pharmacology
  • Tetrodotoxin / pharmacology
  • Veratridine / pharmacology
  • gamma-Aminobutyric Acid / pharmacology

Substances

  • Neurotransmitter Agents
  • Serotonin
  • Substance P
  • Neurotensin
  • Tetrodotoxin
  • Somatostatin
  • gamma-Aminobutyric Acid
  • Enkephalin, Methionine
  • Veratridine
  • Potassium
  • Norepinephrine